Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Seadrill New Finance Limited (the “Issuer”) – Successful Completion of Consent Solicitation

Hamilton, Bermuda | July 12, 2021 - Seadrill Limited (“Seadrill” or the “Company”) (OSE: SDRL, OTCPK:SDRLF) and the Issuer announce, further to the announcement made by Seadrill and the Issuer on July 2, 2021, the successful completion of the consent solicitation process (the “Consent Solicitation”) to amend certain terms of the indenture (the “Indenture”), dated as of July 2, 2018, and as amended and supplemented by that certain first supplemental indenture dated as of March 11, 2019, related to the Issuer’s outstanding 12.0% Senior Secured Notes due 2025 (the “Notes”). The Consent

Triton Fund III to divest entire holding in Polygon

The majority owner of Polygon group, Triton Fund III, has signed an agreement to sell its investment in the Polygon group (the “Transaction”).The completion of the Transaction will trigger a change of control under the terms and conditions of the Swedish law governed EUR 250,000,000 senior secured fixed rate notes issued by Polygon AB (publ) (the “Company”), entitling the note holders to – following completion of the Transaction – request that all or some of the notes are repurchased at price per note of 101 per cent. of the nominal amount together with accrued but unpaid interest. As

PRECLINICAL BEMCENTINIB AND TILVESTAMAB DATA PRESENTED AT EAU 2021

Bergen, Norway, 10 July 2021 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, announces that preclinical data from a study investigating the anti-tumor efficacy of BerGenBio’s AXL-inhibitors bemcentinib and tilvestamab in renal cell carcinoma (RCC) was presented at the European Association of Urology 2021 virtual congress. Data from the study, conducted by researchers at the University of Bergen, Department of Clinical Medicine, showed that both bemcentinib and tilvestamab prevented

FREYR AS and Alussa Energy Acquisition Corp. Complete Business Combination

NEW YORK, NY and OSLO, Norway, July 9, 2021 – FREYR AS, a Norway-based developer of clean, next-generation battery cell production capacity, and Alussa Energy Acquisition Corp. (“Alussa Energy”) (NYSE: ALUS), a Cayman Island exempted special purpose acquisition company, announced the completion of their previously announced business combination (the “Business Combination”). The Business Combination, which is effective today, was approved at the special meeting of shareholders of Alussa Energy on June 30, 2021. The combined company now operates as FREYR Battery (“FREYR”) and its common

Klarna acquires HERO to bring best of in-store experience to social shopping for its 90m consumers

London and New York -  9 July 2021 – Klarna, a leading global retail bank, payments and shopping service, today announces the acquisition of HERO, a social shopping platform designed to provide consumers with inspiration, advice and immediately shoppable content produced directly from retailers’ physical stores.  Klarna will introduce HERO to its 250,000 retail partners, allowing their in-store teams to become content creators instantly, offering reviews, real-time advice and richer, more engaging and informative content around products to bring the best of in-store shopping to the

Read original

Aros Bostad enters into agreement to divest two residential development projects for MSEK 850

Aros Bostadsutveckling AB publ (”Aros Bostad”) has signed an agreement regarding divestment of two residential development projects, formed by the first phase of the residential area Viggby Ängar in Täby and the third phase of O2 Orminge in Nacka. The purchase price is MSEK 850 and the buyer is CBRE Global Investors, on behalf of a pan European fund.The development project Viggby Ängar in Täby, which is fully owned by Aros Bostad, comprises four phases with a total of 247 apartments. The first phase consists of a building with 102 apartments, which is under construction with an estimated

EQT Infrastructure acquires Meine Radiologie and Blikk to form a leading radiology and radiotherapy provider in Germany

· Meine Radiologie and Blikk operate more than 65 radiology and radiotherapy locations in Germany – together they will form a leading radiology provider  · EQT Infrastructure intends to combine both companies to create a leading platform in an essential and fast-growing sub-sector in social infrastructure and healthcare · Following the closing, EQT Infrastructure will support the combined group’s strive for medical excellence, expand its capabilities in adjacent specialties and drive its digital agenda to become a patient-centric and tech-enabled diagnostic imaging provider, with

Hansa Biopharma announces long term follow-up data demonstrating 3-year graft survival of 84% after imlifidase treatment and transplantation

· Three-year overall allograft survival was 84% in crossmatch positive patients treated with imlifidase. · In patients with a cPRA of ≥99.9%, three-year allograft survival was 92% · Data published in an article accepted by the American Journal of Transplantation Lund, Sweden July 9, 2021. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced three-year follow-up data in crossmatch positive patients who received imlifidase prior to kidney transplantation.[1] As reported in the article, which has been

ShaMaran Update on Atrush CK-17 Production Well

VANCOUVER, BC, July 9, 2021 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the “Company”) (SNM - TSXV, Nasdaq First North Growth Market) refers to the Company’s news release dated June 4, 2021 that announced the TD of the Atrush CK-17 production well (“CK-17”) and is pleased to make the following update that CK-17 has been delivered under budget during Q2 2021, has been bought on-line on June 11, 2021 and has been producing at approximately 2,000 bopd to increase Atrush gross production rate to be in excess of 44,000 bopd. Atrush drilling and completion operations, suspended in 2020 due

KEBNI FILES INERTIAL SENSING PATENT APPLICATION FOR NEW USE-CASE IN PERSONAL SAFETY

KebNi files a patent application in support of a personal safety use-case based on Inertial Sensing expertiseStockholm, 9 July 2021 - KebNi AB (publ) has filed a new patent application regarding structural status monitoring and personal safety on scaffolding. KebNi CEO Torbjörn Saxmo explains "Personal safety on scaffolding is a global challenge. We've identified an innovative way of using our expertise to monitor the scaffolding safety in a reliable, easy, cost-efficient and integrity friendly manner. Partnering with the industry leader to gain reach quickly, we intend to help mitigate

#21-233 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Normalized demand, not regulation, will solve supply chain delays

Washington, 9 July 2021 - The Covid-19 cargo congestion brought on by extreme demand in combination with operational disruptions is very real and felt across supply chains globally. In the U.S. in particular, all parts of the supply chain are facing unprecedented pressures – there is a lack of rail and truck capacity, warehouses are full, and ports are bursting at the seams. It is in part in this context that the President is issuing an Executive Order that addresses shipping along with other industries.The driver of these problems is demand for imports by U.S. consumers and U.S. businesses.

Stena Rederi is Exploring Potential Expansion in the Port of Ventspils

Stena Rederi AB (“Stena”) and  Ventspils Port Companies have signed a Letter of Intent regarding the management of their port and logistics activities in Latvia. The intention is to explore the potential of Stena managing the terminals and railway companies on behalf of Ventspils Port Companies.“Stena Rederi operates several European ports and understands the strategic importance and potential  of such infrastructure.  We are now investigating the opportunities to contribute to increasing port activities and cargo through-put in the port of  Ventspils “, says Carl-Johan Hagman, CEO Stena

AxFlow Holding AB becomes majority shareholder in Danish System Cleaners

AxFlow Holding AB today announced the acquisition of System Cleaners - a Danish provider of complete open plant cleaning systems and products for the global food and beverage industry.Headquartered in Aalborg, Denmark, System Cleaners delivers fully automatic and manual open plant cleaning systems for the global food and beverage industries that minimize cleaning times, increase factory uptime while reducing water and chemical usage. During their 30 years in business, System Cleaners has become a well-recognised global brand with installed units in more than 100 countries worldwide to

Clean interim safety review of RhoVac’s clinical phase IIb study in prostate cancer

RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today on July 9[th] 2021, that its Safety Monitoring Committee has conducted a planned interim safety review of its clinical phase IIb trial in prostate cancer, known as BRaVac. The safety profile of RV001 was excellent and the Safety Monitoring Committee concluded the trial can continue without modifications.RhoVac started the clinical phase IIb trial (BRaVac) with the company’s drug candidate, RV001, late 2019, in prostate cancer patients with a biochemical recurrence (a rise in PSA) after curative intent therapy. In

Per Nilsson to become new CEO of John Mattson

The Board of Directors has appointed Per Nilsson as John Mattson’s new CEO. He succeeds Siv Malmgren, who is retiring. Per Nilsson has broad property competence, including many years of experience in development and management, and comes most recently from Klövern AB in Stockholm.Since 2014, Per Nilsson has had several managerial roles at Akademiska Hus and Klövern, most recently as Head of Project Development Stockholm North/East for Klövern. He has also worked as a management consultant with assignments in the construction industry, among others, and has also worked in the aluminium

General Meeting Notice Amendment

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL BE CONSTRUED AS AN OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THIS

Elkem ASA - Invitation to second quarter 2021 results presentation

Oslo, 9 July 2021 Elkem ASA will release its report for the second quarter 2021 on Friday, 16 July 2021 at 7.00 a.m. CET. The quarterly report and presentation material will be made available at this time at www.elkem.com In connection with the quarterly report the company will host a webcast presentation at 8.00 a.m. The webcast presentation will be available here . The presentation and the subsequent Q&A session will be held in English. For further information, please contact: Odd-Geir LyngstadVP Finance

WISA Woodsat was tested at ESTEC

(UPM, Helsinki, 9 July 2021 at 15:00 EEST) – WISA Woodsat satellite was put through rigorous tests during this week at ESTEC, the technical centre of the European Space Agency located in the Netherlands. The world’s first wooden satellite is now certified for a rocket ride and the final pre-launch phase can begin. The model used for the tests was an exact copy of the actual satellite to be launched to space. The satellite was subjected to a rigorous vibration test, mimicking a ride to space atop of a rocket shaken by the engines. The satellite also faces hard acoustic noise from the

The Board of Directors of Tecnotree Corporation decided on a new stock option plan

Tecnotree Corporation Stock Exchange Release 9 Jul 2021 at 14:33 EETThe Board of Directors of Tecnotree Corporation has resolved to launch a new stock option plan directed to the Group key employees. The company has a weighty financial reason for the issue of stock options, since the stock options are intended to form part of the incentive and commitment program for the key employees. The purpose of the stock options is to encourage the key employees to work on a long-term basis to increase shareholder value. The purpose of the stock options is also to commit the key employees to the

Notice to the Extraordinary General Meeting of Tecnotree Corporation

Tecnotree Corporation Stock Exchange Release 9 Jul 2021 at 14:32 EETNotice is given to the shareholders of Tecnotree Corporation (“Tecnotree” or the “Company”) to the Extraordinary General Meeting to be held on Friday 30 July 2021 at 10.00 a.m. (EEST) at the head office of the Company, address Tekniikantie 14, 02150 Espoo. The Company’s Board of Directors has resolved on exceptional meeting procedures based on the temporary legislative act (375/2021) which entered into force on 8 May 2021. In order to curb the spread of the COVID-19 pandemic, the Extraordinary General Meeting will be

Tecnotree receives 22 Mn Euro investment offer - plans directed share issue

Tecnotree Corporation Stock Exchange Release 9 Jul 2021 at 14:31 EETTecnotree Corporation (the “Company”) is planning a directed share issue to raise approximately EUR 22 million in gross proceeds. The purpose of the planned directed issue is to support the debt repayment capability and strengthen the working capital of the Company. The Company is planning to issue a maximum of 30,577,778 new shares, which is equal to approximately 10.8 per cent of the total number of the Company’s current shares, in a directed share issue in deviation from the shareholders’ pre-emptive subscription

There are no items matching the current filter
There are no more items matching the current filter
Back to top